Mark William Ahrens-Townsend, President & Chief Executive Officer at Kane Biotech, holds 1.29M shares in Kane Biotech (Ticker: TSE:KNE). Most recently, Mark William Ahrens-Townsend Bought C$20,000 shares of Kane Biotech on Mar 28, 2018 for an estimated value of 1.90K.
What is the percentage of profitable transactions made by Mark William Ahrens-Townsend?
The percentage of profitable transactions made by Mark William Ahrens-Townsend is 33%.
What is the average return per transaction made by Mark William Ahrens-Townsend?
The average return per transaction made by Mark William Ahrens-Townsend is -15.60%.
What stocks does Mark William Ahrens-Townsend hold?
Mark William Ahrens-Townsend holds: TSE:KNE stocks.
What was Mark William Ahrens-Townsend’s latest transaction?
Mark William Ahrens-Townsend latest transaction was an Informative Buy of C$1.90K.
What was Mark William Ahrens-Townsend's most profitable transaction?
Mark William Ahrens-Townsend’s most profitable transaction was an Informative Buy of TSE:KNE stock on June 11, 2015. The return on the trade was 14.30%.
What is Mark William Ahrens-Townsend's role in Kane Biotech?
Mark William Ahrens-Townsend's role in Kane Biotech is President & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.